Healthcare Triangle, Inc. 8-K/A Filing
Ticker: HCTI · Form: 8-K/A · Filed: Sep 2, 2025 · CIK: 1839285
| Field | Detail |
|---|---|
| Company | Healthcare Triangle, Inc. (HCTI) |
| Form Type | 8-K/A |
| Filed Date | Sep 2, 2025 |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K/A filing submitted by Healthcare Triangle, Inc. (ticker: HCTI) to the SEC on Sep 2, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.00001 (ch registered Common Stock, par value $0.00001 per share HCTI The Nasdaq Stock Mar).
How long is this filing?
Healthcare Triangle, Inc.'s 8-K/A filing is 4 pages with approximately 1,312 words. Estimated reading time is 5 minutes.
Where can I view the full 8-K/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,312 words · 5 min read · ~4 pages · Grade level 11.9 · Accepted 2025-08-29 17:52:41
Key Financial Figures
- $0.00001 — ch registered Common Stock, par value $0.00001 per share HCTI The Nasdaq Stock Mar
Filing Documents
- ea0255323-8ka1_health.htm (8-K/A) — 35KB
- ea025532301ex10-1_health.htm (EX-10.1) — 15KB
- ea025532301ex99-1_health.htm (EX-99.1) — 6KB
- ea025532301ex99-2_health.htm (EX-99.2) — 10KB
- ea025532301ex99-3_health.htm (EX-99.3) — 40KB
- ex99-1_001.jpg (GRAPHIC) — 819KB
- ex99-1_002.jpg (GRAPHIC) — 319KB
- ex99-1_003.jpg (GRAPHIC) — 364KB
- ex99-1_004.jpg (GRAPHIC) — 341KB
- ex99-1_005.jpg (GRAPHIC) — 220KB
- ex99-1_006.jpg (GRAPHIC) — 293KB
- ex99-1_007.jpg (GRAPHIC) — 816KB
- ex99-1_008.jpg (GRAPHIC) — 907KB
- ex99-1_009.jpg (GRAPHIC) — 784KB
- ex99-2_001.jpg (GRAPHIC) — 1590KB
- ex99-2_002.jpg (GRAPHIC) — 816KB
- ex99-2_003.jpg (GRAPHIC) — 203KB
- ex99-2_004.jpg (GRAPHIC) — 240KB
- ex99-2_005.jpg (GRAPHIC) — 173KB
- ex99-2_006.jpg (GRAPHIC) — 226KB
- ex99-2_007.jpg (GRAPHIC) — 414KB
- ex99-2_008.jpg (GRAPHIC) — 453KB
- ex99-2_009.jpg (GRAPHIC) — 440KB
- ex99-2_010.jpg (GRAPHIC) — 332KB
- ex99-2_011.jpg (GRAPHIC) — 240KB
- ex99-2_012.jpg (GRAPHIC) — 228KB
- ex99-2_013.jpg (GRAPHIC) — 117KB
- 0001213900-25-082708.txt ( ) — 14516KB
- hcti-20250616.xsd (EX-101.SCH) — 3KB
- hcti-20250616_lab.xml (EX-101.LAB) — 33KB
- hcti-20250616_pre.xml (EX-101.PRE) — 22KB
- ea0255323-8ka1_health_htm.xml (XML) — 5KB
01 Entry into a Material Definitive
Item 1.01 Entry into a Material Definitive Agreement. On August 28, 2025, the Company and Niyama Healthcare, Inc. entered into Amendment No. 1 to their Asset Transfer Agreement dated June 16, 2025. Amendment No. 1 replaces Clause (ii) of Section 1(b) of the Agreement to provide that the Seller will receive 1,388,041 restricted shares of the Company's common stock, issuable on the effective date after receiving approval of such issuance by a majority of the voting power of the Company's voting stock. The amendment reflects the Company's 1-for-249 reverse stock split and otherwise leaves the Agreement in full force and effect. The foregoing summary is qualified in its entirety by the text of Amendment No. 1 to Asset Transfer Agreement, filed as an exhibit to this Amendment as Exhibit 10.1, and incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (a) Financial statements of businesses acquired. The audited balance sheet of Niyama as of December 31, 2024 and 2023 and the audited statements of operations, changes in stockholder' equity, and cash flows for the years ended December 31, 2024 and 2023, and the related notes thereto, are filed herewith and attached hereto as Exhibit 99.1, and are incorporated herein by reference. The audited balance sheet of Ezovion as of December 31, 2024 and 2023 and the audited statements of operations, changes in stockholder' equity, and cash flows for the years ended December 31, 2024 and 2023, and the related notes thereto, are filed herewith and attached hereto as Exhibit 99.2, and are incorporated herein by reference. (b) Pro forma financial information. The Unaudited Pro Forma Condensed Combined Financial Information of the Company, giving effect to the transaction described in the Original Report, prepared in accordance with Article 11 of Regulation S-X, is filed as Exhibit 99.3 to this Amendment. (d) Exhibits. Exhibit No. Description 10.1 Amendment No. 1 to Asset Transfer Agreement, dated August 28, 2025, by and between Healthcare Triangle, Inc. and Niyama Healthcare, Inc. 99.1 Audited Financial Statements of Niyama Healthcare, Inc. as of December 31, 2024 and 2023 and for the years ended December 31, 2024 and 2023. 99.2 Audited Financial Statements of Ezovion Solutions Private Limited as of December 31, 2024 and 2023 and for the years ended December 31, 2024 and 2023. 99.3 Unaudited pro forma condensed combined financial information of Healthcare Triangle, Inc., Niyama Healthcare, Inc. and Ezovion Solutions Private Limited as of and for the period ended June 30, 2025 and for the fiscal year ended December 31, 2024
Forward-Looking Statements
Forward-Looking Statements Certain statements made in this Current Report on Form 8-K are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this Current Report on Form 8-K are
forward-looking statements. When used in this Current Report on Form 8-K, words such as "anticipate," "believe,"
forward-looking statements. When used in this Current Report on Form 8-K, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and variations of these words or similar expressions (or the negative versions of such words or expressions), as they relate to the Company or its management team, are intended to identify forward-looking statements. Many factors could cause actual future events to differ materially from the forward-looking statements in this Current Report on Form 8-K, including the Company's ability to successfully appeal the Nasdaq staff's delisting determination and the Company's ability to have an application to trade on the OTCQB approved timely to commence trading if its common shares are delisted from Nasdaq. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company's management. Forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of the Company, including those set forth in the "Risk Factors" section of the Company's Annual Report on Form 10-K filed on March 31, 2025, and other reports and registration statements of the Company filed, or to be filed, with the Securities and Exchange Commission, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. All subsequent written or oral forward-looking undertakes no obligation to update or revise any forward-looking statements for revisions or changes after the date of this Current Report on Form 8-K, except as
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Healthcare Triangle, Inc. Dated: August 29, 2025 By: /s/ David Ayanoglou David Ayanoglou Chief Financial Officer 3